Treating older adults with schizophrenia: Challenges and opportunities

Schizophrenia Bulletin

Volumn 39, Issue 5, 2013, Pages 966-968

  Jeste, Dilip V ^a   Maglione, Jeanne E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; antipsychotics; cognition; psychosis; psychosocial treatments; schizophrenia

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT DISEASE; AGING; HUMAN; MORTALITY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REMISSION; REVIEW; SCHIZOPHRENIA; SOCIAL ADAPTATION; TREATMENT PLANNING;

AGING; ANTIPSYCHOTICS; COGNITION; PSYCHOSIS; PSYCHOSOCIAL TREATMENTS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HUMANS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84883472017     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt043     Document Type: Review

References (15)

1. Bola JR. Medication-free research in early episode schizophrenia: Evidence of long-term harm? Schizophr Bull. 2006;32:288-296
2. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131
3. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year followup of mortality in patients with schizophrenia: A population- based cohort study (FIN11 study). Lancet. 2009;374: 620-627
4. Sweet RA, Pollock BG. New atypical antipsychotics. Experience and utility in the elderly. Drugs Aging. 1998;12:115-127
5. Rowell FJ, Hui SM, Fairbairn AF, Eccleston D. The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum. Br J Clin Pharmacol. 1980;9:432-434
6. Uchida H, Kapur S, Mulsant BH, Graff-Guerrero A, Pollock BG, Mamo DC. Sensitivity of older patients to antipsychotic motor side effects: A PET study examining potential mechanisms. Am J Geriatr Psychiatry. 2009;17:255-263
7. Jeste DV, Wolkowitz OM, Palmer BW. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull. 2011;37:451-455
8. Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry. 2000;157:172-178
9. Folsom DP, Depp C, Palmer BW, et al. Physical and mental health-related quality of life among older people with schizophrenia. Schizophr Res. 2009;108:207-213
10. Auslander LA, Jeste DV. Sustained remission of schizophrenia among community-dwelling older outpatients. Am J Psychiatry. 2004;161:1490-1493
11. Jin H, Shih PA, Golshan S, et al. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: A trial using equipoise-stratified randomization. J Clin Psychiatry. 2013;74:10-18
12. Granholm E, McQuaid JR, McClure FS, et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. J Clin Psychiatry. 2007;68:730-737
13. Patterson TL, Mausbach BT, McKibbin C, Goldman S, Bucardo J, Jeste DV. Functional adaptation skills training (FAST): A randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophr Res. 2006;86:291-299
14. Mueser KT, Pratt SI, Bartels SJ, et al. Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. J Consult Clin Psychol. 2010;78:561-573
15. Depp CA, Mausbach B, Granholm E, et al. Mobile interventions for severe mental illness: Design and preliminary data from three approaches. J Nerv Ment Dis. 2010;198:715-721